Former KENS Anchor Clarke Romo Reveals Her Progress After Brain Injury
KENS San Antonio anchor Clarke Finney Romo suffered a hypoxic brain injury more than a year ago.
In January 2024, she told viewers her injury meant that she had to 'relearn everything.'
She recently updated her health status by posting about her progress on social media.
'Hey everyone I just wanted to let you know how well I have progressed. My writing and typing has gotten so much better and I want to thank everyone who has shared there time and prayers with me because it means a lot for me to even be here right now. I just wanted to share how far my recovery has come along.'
MySA said Romo last appeared on-air in October 2023 as the co-host of Great Day SA. Her bio is no longer on the KENS website.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
19 minutes ago
- Miami Herald
Gambler bets some change on a slot machine in Florida — and wins big jackpot
A gambler bet 88 cents on a slot machine at a Florida casino and won a big jackpot prize. The lucky player sat at a Fu Nan Fu Nu slot machine June 8 at Seminole Brighton Bay Hotel & Casino in Okeechobee, the casino said in a news release. The guest made a bet, hit spin and watched as the symbols flashed across the screen until a jackpot message appeared. The gambler then walked away $75,174.41 richer. Okeechobee is about a 70-mile drive northwest from West Palm Beach. Another gambler on the other side of the country also hit a slot machine jackpot with an 88-cent bet. The visitor sat at a Dancing Drums slot machine at Palms Casino Resort in Las Vegas and won a $28,733.01 jackpot, McClatchy News reported.
NZ Herald
19 minutes ago
- NZ Herald
Fieldays 2025: Farmers expected to come on board as methane science advances
By Eloise Gibson of RNZ The Prime Minister's new chief science adviser believes farmers will come around to technologies that cut their emissions. Some farming groups oppose inventions like methane vaccines, but John Roche says farmers will accept change once they see the products work. For a long time, one
Yahoo
19 minutes ago
- Yahoo
Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit
Johnson & Johnson (NYSE:JNJ) is one of the best Dow stocks to invest in. Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded last month that the company had broken antitrust laws by withholding support from hospitals that used reprocessed catheters. U.S. District Judge James Selna ordered the company to pay three times the $147 million in damages awarded by the jury, as permitted under antitrust regulations. This sum does not include legal fees or other related costs. Daniel Vukelich, CEO of the Association of Medical Device Reprocessors, described the decision as 'a seismic result.' In response, a Johnson & Johnson (NYSE:JNJ) spokesperson said the company intends to appeal the verdict but will comply with the court's decision and any required relief for now. The spokesperson added, 'We strongly disagree with the jury's verdict and believe it will not withstand appellate review.' Innovative Health sued Johnson & Johnson (NYSE:JNJ)'s Biosense Webster in 2019, claiming the company used its market power to block hospitals from using reprocessed heart-mapping catheters by tying support for its Carto 3 system to purchases of its own products. A jury found Johnson & Johnson (NYSE:JNJ) violated antitrust laws by withholding support for the reprocessed devices. AMDR's CEO said the ruling signals that anti-competitive tactics against reprocessing won't be tolerated. The case was heard in the U.S. District Court for the Central District of California. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.
